A serological assay to detect SARS-CoV-2 seroconversion in humans

Journal: Nature Medicine

Published: 2020-05-12

DOI: 10.1038/s41591-020-0913-5

Affiliations: 21

Authors: 30

Go to article
Institutions Share
Icahn School of Medicine at Mount Sinai (ISMMS), MSHS, United States of America (USA) 0.66
The Peter Doherty Institute for Infection and Immunity (Doherty Institute), Australia 0.07
Global Health and Emerging Pathogens Institute, ISMMS, United States of America (USA) 0.05
Division of Pulmonary, Critical Care and Sleep Medicine, ISMMS, United States of America (USA) 0.03
Department of Physiology and Biophysics, UCI, United States of America (USA) 0.03
Faculty of Medicine, University of Helsinki, Finland 0.03
Department of Biotechnology (DBT), BOKU, Austria 0.02
Department of Genetics and Genomic Sciences, ISMMS, United States of America (USA) 0.02
School of Public Health and Preventive Medicine, Monash University, Australia 0.02
Infection Prevention and Healthcare Epidemiology Unit, Alfred Health, Australia 0.02
Vetsuisse Faculty, UZH, Switzerland 0.02
Department of Veterinary Biosciences, University of Helsinki, Finland 0.01
HUCH Laboratory of Helsinki University Hospital (HUSLAB), Finland 0.01
Mount Sinai Queens, MSHS, United States of America (USA) 0.01
Tisch Cancer Institute (TCI), ISMMS, United States of America (USA) 0.01

Return

Except where otherwise noted © 2020 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER